Bruker Names Immunology Entrepreneur Eicke Latz to Board
Bruker adds immunology researcher and five-time biotech co-founder Eicke Latz to its board effective January 1, 2027, betting on drug-development insight for its life-science tools strategy.
Topic
Topic
Bruker adds immunology researcher and five-time biotech co-founder Eicke Latz to its board effective January 1, 2027, betting on drug-development insight for its life-science tools strategy.